Public Alert No. 07/2024 – Alert on Suspected Falsified Chloroquine Tablets
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public of the sale of the falsified brand of Chloroquine Phosphate tablets. The fake product was discovered and purchased from an informal dispensary in Jos, Plateau State, Nigeria. TLC screening conducted on the tablets revealed that the product contains No active pharmaceutical […]
Public Alert No. 06/2024 – Alert on Sale of Falsified and Unregistered Oxytocin Injection in Nigeria
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public of the sale of falsified and unregistered brands of Oxytocin Injection in Nigeria. These products were discovered during the Risk-Based Post Marketing Surveillance (RBPMS) activities carried out by the Post Marketing Surveillance Directorate of the Agency. Initial Physical screening revealed […]
NAFDAC Update on ”Mis-information on Nearly all Paracetamol Tablets in Nigeria are Possibly Under Dosed”
RE: PUBLICATION – “NEARLY ALL PARACETAMOL TABLETS IN NIGERIA ARE POSSIBLY UNDERDOSED”RESPONSE FROM NAFDAC – PARACETAMOL TESTED IN NAFDAC LAGOS WHO PREQUALIFIED LABORATORY.PUBLICATION IS FALSE AND UNSCIENTIFIC!!22nd January, 2024 The National Agency for Food and Drug Administration and Control (NAFDAC) issued a press release on Monday 14/01/2024 as an initial response to the above subject […]
Public Alert No. 05/2024 – Sales of Unregistered Seretide Accuhaler on Instagram and Online Media
The National Agency for Food and Drug Administration and Control (NAFDAC) is notifying the public of the sales of unregistered Seretide Accuhaler on Instagram and online media. On investigation, a team of NAFDAC officials visited the two addresses and got the unregistered Seretide Accuhaler in one of the locations specifically 14 Lanre Hassan Street by […]
Public Alert No. 04/2024 –Alert on recall of Brexafemme® tablets 150 mg due to risk of cross-contamination
The National Agency for Food and Drugs Administration and Control (NAFDAC) is informing the public that Scynexis, Inc is conducting a voluntary nationwide recall of two (2) lots of BREXAFEMME® (ibrexafungerp tablets) 150 mg to the consumer level in the US market as reported by the United States (US) Food and Drug Administration (FDA). This recall is due […]
Public Alert No. 03/2024 – Alert on Sale of Counterfeit Arla Dano Full Cream Milk Powder- 14g Sachet Across Nigerian Market
The National Agency for Food and Drug Administration and Control (NAFDAC) is notifying the public of the sale of counterfeit Arla Dano 14g full cream Milk Powder across states in Nigeria. Investigations by the TG Arla Dairy Product Enterprise company (Holder of Certificate of Registration) discovered that the counterfeited products were displayed openly in the market. The details of […]
Public Alert No. 02/2024 –Pfizer warns against Tampered Expiry date on Prevenar 13 batch CL 3337
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying healthcare providers that Pfizer has warned on the presence of boxes of probable authentic Prevenar 13 displaying tampered expiry date. According to the Marketing Authorization Holder (MAH) Pfizer, a patient notification received from Nigeria informed the company of a suspicious pack of […]
Public Alert No. 01/2024 –Alert on falsely labelled OZEMPIC (Semaglutide, 1 mg, solution for injection) Pens
The National Agency for Food and Drugs Administration and Control (NAFDAC) is informing the public about the circulation of pre-filled pens falsely labeled as the diabetes medicine, Ozempic (semaglutide, 1 mg, solution for injection) which was identified at wholesalers in the European Union and the UK as reported by the European Medicines Agency (EMA). The […]
Opening Remarks By Prof. Mojisola Christianah Adeyeye, At The Commissioning Of The Narcotic Drugs Serialization Pilot Project On Thursday January 18, 2024
Opening Remark By Prof. Adeyeye C. M Director General NAFDAC Commissioning Of The Narcotic Drugs Serialization Pilot Project Lagos, Nigeria 18th January, 2024. Honourable guests, distinguished colleagues, ladies and gentlemen of the press. All protocols duly observed. It is with great pleasure and enthusiasm that I welcome you to this historic event, the commissioning of […]
Public Alert No. 037/2023 – Alert on Substandard (contaminated) syrup and suspension medicines identified in the WHO Regions of the Americas, Eastern Mediterranean, South-East Asia and Western Pacific
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying Healthcare providers and the general public of the WHO Medical Product Alert referring to five different Oral liquid dosage forms (syrup and suspension) detected in the Maldives and Pakistan. Some of the affected products have also been detected in Belize, Fiji and […]
